Methotrexaat: hoeksteen van de behandeling van reumatoïde artritis.

Translated title of the contribution: [Methotrexate: mainstay of rheumatoid arthritis treatment].

J. W.G.Hans Jacobs*, J. W.J.Hans Bijlsma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

Some accidents due to methotrexate (MTX) have been reported to the Dutch Health Authorities. However, for modern, intensive treatment of patients with rheumatoid arthritis and various other chronic autoimmune diseases, we cannot do without the drug, because of its broad applications and unique properties. Fortunately, it is a safe drug, if used by doctors experienced in using it and who follow MTX guidelines.

Translated title of the contribution[Methotrexate: mainstay of rheumatoid arthritis treatment].
Original languageDutch
JournalNederlands Tijdschrift voor Geneeskunde
Volume153
Publication statusPublished - 1 Dec 2009

Fingerprint

Dive into the research topics of '[Methotrexate: mainstay of rheumatoid arthritis treatment].'. Together they form a unique fingerprint.

Cite this